Context Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
February 24, 2025 17:05 ET | Source: Context Therapeutics Inc. PHILADELPHIA, Feb.…
Context Therapeutics Announces First Patient Dosed in the Phase 1 Clinical Trial of CTIM-76
January 14, 2025 16:58 ET | Source: Context Therapeutics Inc. CTIM-76 Phase 1…